{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:24:31Z","timestamp":1772753071013,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Ministry of Education, Culture, Sports, Science, and Technology (JP)","award":["26293057"],"award-info":[{"award-number":["26293057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12964-016-0151-0","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T12:26:06Z","timestamp":1479731166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue"],"prefix":"10.1186","volume":"14","author":[{"given":"Yutaro","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Min","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako C.","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Sabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"key":"151_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"151_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase iii comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92\u20138.","journal-title":"J Clin Oncol"},{"key":"151_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO;2-1","volume":"59","author":"M Al-Sarraf","year":"1987","unstructured":"Al-Sarraf M, Pajak TF, Marcial VA, et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study. Cancer. 1987;59:259\u201365.","journal-title":"Cancer"},{"key":"151_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"151_CR5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hed.21801","volume":"34","author":"F Bhaijee","year":"2012","unstructured":"Bhaijee F, Pepper DJ, Pitman KT, et al. Cancer stem cells in head and neck squamous cell carcinoma: A review of current knowledge and future applications. Head Neck. 2012;34:894\u20139.","journal-title":"Head Neck"},{"key":"151_CR6","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1073\/pnas.0401753101","volume":"101","author":"S Hashimoto","year":"2004","unstructured":"Hashimoto S, Onodera Y, Hashimoto A, et al. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A. 2004;101:6647\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"151_CR7","doi-asserted-by":"crossref","first-page":"37677","DOI":"10.1074\/jbc.M404196200","volume":"279","author":"S Hashimoto","year":"2004","unstructured":"Hashimoto S, Hashimoto A, Yamada A, et al. A novel mode of action of an ArfGAP, AMAP2\/PAG3\/Pap\u03b1, in Arf6 function. J Biol Chem. 2004;279:37677\u201384.","journal-title":"J Biol Chem"},{"key":"151_CR8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.emboj.7600588","volume":"24","author":"Y Onodera","year":"2005","unstructured":"Onodera Y, Hashimoto S, Hashimoto A, et al. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J. 2005;24:963\u201373.","journal-title":"EMBO J"},{"key":"151_CR9","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.0509166103","volume":"103","author":"S Hashimoto","year":"2006","unstructured":"Hashimoto S, Hirose M, Hashimoto A, et al. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3\/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2006;103:7036\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"151_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ncb1672","volume":"10","author":"M Morishige","year":"2008","unstructured":"Morishige M, Hashimoto S, Ogawa E, et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol. 2008;10:85\u201392.","journal-title":"Nat Cell Biol"},{"key":"151_CR11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1083\/jcb.200712086","volume":"182","author":"M Hirano","year":"2008","unstructured":"Hirano M, Hashimoto S, Yonemura S, et al. EPB41l5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition. J Cell Biol. 2008;182:1217\u201330.","journal-title":"J Cell Biol"},{"key":"151_CR12","doi-asserted-by":"crossref","first-page":"e25301","DOI":"10.1371\/journal.pone.0025301","volume":"6","author":"T Menju","year":"2011","unstructured":"Menju T, Hashimoto S, Hashimoto A, et al. Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma. PLoS One. 2011;6:e25301.","journal-title":"PLoS One"},{"key":"151_CR13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1083\/jcb.201201065","volume":"197","author":"Y Onodera","year":"2012","unstructured":"Onodera Y, Nam JM, Hashimoto A, et al. Rab5c promotes AMAP1-PRKD2 complex formation to enhance \u03b21 integrin recycling in EGF-induced cancer invasion. J Cell Biol. 2012;197:983\u201396.","journal-title":"J Cell Biol"},{"key":"151_CR14","doi-asserted-by":"crossref","first-page":"e76791","DOI":"10.1371\/journal.pone.0076791","volume":"8","author":"R Kinoshita","year":"2013","unstructured":"Kinoshita R, Nam JM, Ito YM, et al. Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy. PLoS One. 2013;8:e76791.","journal-title":"PLoS One"},{"key":"151_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-12-17","volume":"12","author":"H Sato","year":"2014","unstructured":"Sato H, Hatanaka KC, Hatanaka Y, et al. High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients. Cell Commun Signal. 2014;12:17.","journal-title":"Cell Commun Signal"},{"key":"151_CR16","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1038\/ncomms10656","volume":"7","author":"S Hashimoto","year":"2016","unstructured":"Hashimoto S, Mikami S, Sugino H, et al. Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nat Commun. 2016;7:10656.","journal-title":"Nat Commun"},{"key":"151_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1083\/jcb.201510002","volume":"213","author":"A Hashimoto","year":"2016","unstructured":"Hashimoto A, Oikawa T, Hashimoto S, et al. P53- and mevalonate pathway-driven malignancies require arf6 for metastasis and drug resistance. J Cell Biol. 2016;213:81\u201395.","journal-title":"J Cell Biol"},{"key":"151_CR18","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1038\/oncsis.2016.60","volume":"5","author":"A Hashimoto","year":"2016","unstructured":"Hashimoto A, Hashimoto S, Sugino H, et al. ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis, and drug resistance. Oncogenesis. 2016;5:e259.","journal-title":"Oncogenesis"},{"key":"151_CR19","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1158\/1078-0432.CCR-11-0690","volume":"17","author":"M Zhao","year":"2011","unstructured":"Zhao M, Sano D, Pickering CR, et al. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res. 2011;17:7248\u201364.","journal-title":"Clin Cancer Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-016-0151-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:05:25Z","timestamp":1498363525000},"score":1,"resource":{"primary":{"URL":"http:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-016-0151-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/s12964-016-0151-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,21]]},"article-number":"28"}}